Markets Stocks Economy Crypto Earnings Banking Energy
Home Banking Feature
Banking · Exclusive

BofA says Emirates NBD's growth story is mispriced, lifts target

BofA says Emirates NBD's growth story is mispriced, lifts target
Banking · 2026
Photo · Thomas Brannstrom for Daily Digest Invest
By Thomas Brannstrom Banking & Credit Aug 27, 2026 4 min read

Bank of America Global Research has named Emirates NBD one of its “10 Emerging stocks for 2026,” arguing that the UAE lender’s growth and profitability outlook is not yet reflected in its share price. The bank also raised its price target on the stock to 38.50 dirhams, signaling confidence in the company’s trajectory.

Despite this optimism, Emirates NBD still trades at a roughly 29% discount to its UAE peers on a price-to-book basis. That gap is at the heart of BofA’s thesis: the market is pricing in more risk than the bank’s fundamentals justify.

Why the discount?

Bank valuations often come down to a trade-off: how much profit a bank can generate from shareholders’ money, and how risky investors think those profits are. The price-to-book ratio—which compares a bank’s market value to its net assets—is a common yardstick. A discount suggests investors see higher risk or lower growth potential relative to peers.

BofA thinks Emirates NBD is being judged too harshly on that second part. The firm expects loan growth of about 17% in 2026 (excluding RBL), stronger fee income, and more diversification through India, which it says could make earnings steadier than in past cycles.

That diversification matters. Historically, Gulf banks have been heavily tied to oil prices and domestic economic cycles. Expanding into India, a fast-growing market with a large banking sector, could reduce that dependence and smooth out earnings over time.

What the bank’s growth story looks like

Emirates NBD is one of the largest banking groups in the Middle East, with a strong retail and corporate franchise in the UAE. Its growth plans include a bigger push into India, where it already has a presence. BofA’s analysts see this as a key driver of future earnings, alongside robust loan demand in its home market.

The 17% loan growth forecast is notable. For context, many global banks are struggling to grow loans in the low single digits. If Emirates NBD can deliver that pace, it would put the bank in a select group of high-growth lenders.

Fee income is another area of focus. Banks often rely on interest margins, but fees from wealth management, transaction banking, and other services can provide a more stable revenue stream. BofA expects these to strengthen, adding to the bank’s profitability.

What it means for investors

For everyday investors, the key takeaway is that a well-regarded research house sees value in a stock that the broader market has been cautious about. The 29% discount to peers suggests that if the bank meets its growth targets, the share price could re-rate higher.

However, it’s important to remember that price targets are just one analyst’s view. They are not guarantees. The bank’s performance will depend on economic conditions in the UAE and India, as well as global interest rates and geopolitical risks.

Investors should also consider that emerging market stocks can be more volatile than developed market ones. Currency fluctuations, regulatory changes, and regional instability can all affect returns.

That said, BofA’s endorsement is a signal that some professional investors see the risk-reward balance as attractive. For those already holding the stock, it may reinforce confidence. For those considering a position, it’s a reason to look more closely at the bank’s fundamentals.

As always, it’s wise to do your own research and consider how any investment fits into your broader portfolio. A single analyst’s view should not be the sole basis for a decision.

For more on how analysts view other growth stories, see our coverage of E.ON's overlooked power grid growth and Iliad's shifting growth engine.

More from this story

Next article · Don't miss

Chip and pharma projects could lift US factory construction above $200B

UBS expects US factory construction to rebound, led by new chip and pharma projects. Manufacturing-related building could top $200 billion by end of next year after a recent slowdown.

Read the story →
Chip and pharma projects could lift US factory construction above $200B